A Healthy Participant Study to Evaluate the Bioequivalence of Form H and Form II Tablets of the Smallpox Antiviral Brincidofovir (BCV)

Introduction: The risk of a smallpox outbreak necessitates ready inventory of antivirals for readiness. Given the potential benefits of smallpox antivirals on other orthopox viruses, the 2022 mpox outbreak highlighted the use of antivirals for severe mpox cases, underlining the criticality of these...

Full description

Saved in:
Bibliographic Details
Main Authors: Mr Dave Cassie, Mrs Vanja Komlenovic, Dr. James McCarty, Dr. Kevin Yeo, Mr Daniel Reynolds
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224005435
Tags: Add Tag
No Tags, Be the first to tag this record!